Hanson Wade Group have taken the decision to cancel this meeting. Please do accept our apologies for any inconvenience or disappointment this will cause.
Please register your interest here if you would like updates on the meeting or topic
CANCELLED - 3rd Non-Viral RNA Delivery Systems Summit
Driving Efficacious RNA Therapeutics with Next Generation Delivery Vehicles
Delivery remains the biggest challenge so far for the RNA community, to get RNA-based therapies to the right cell type with specificity, tolerability and effective targeting.
To address this, RNA science and delivery experts will be uniting at the 3rd Non-Viral RNA Delivery Systems Summit in Boston this October to showcase and deep-dive into the hottest and latest non-viral delivery systems, including novel and innovative LNPs, exosomes, polymers, peptides and more, for RNA-specific payloads, overcoming IP challenges in addition to toxicity and immunogenicity hurdles to advance potent and efficacious therapeutics towards patients in need.
This is your prime opportunity to learn, share and collaborate with 80+ Formulation, Delivery and Chemistry experts including Scientists, Directors, Heads of and VPs from the likes of AstraZeneca, Sanofi, Moderna, Novo Nordisk, Tessera Therapeutics, Omega Therapeutics and more to advance the next generation of delivery vehicles from discovery through to clinic beyond traditional LNPs with improved endosomal escape and extra-hepatic targeting.
What Was in Store for 2024:
gRNA for Genetic Medicines
Hear data driven presentations covering novel and innovative non-viral delivery platforms for RNA payloads including mRNA, siRNA, saRNA and now gRNA for genetic medicines to ensure safe and specific delivery to treat a wide landscape of diseases.
Hear From 80+ Experts
Brand new companies sharing insights at the 2024 meeting, hear from the likes of Capricor Therapeutics, Moderna, Vesigen Therapeutics, Corti Therapeutics, Tessera Therapeutics, Sanofi and more, to stay ahead of the curve.
Your One-Stop Shop
In 2024, even more technical content is being showcased. This meeting is your one-stop shop, uniting technical experts from top RNA companies, who are truly shaping and advancing non-viral delivery systems to capitalize on the full potential of RNA therapeutics in a broad range of diseases.